| Filed On | Filing |
|---|---|
| 24 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On August 17, 2026, Krishna Gupta, a Class I member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of his resignation from the Board and position on the Nominating and Corpora... |
| 24 Jul 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
This letter agreement (the “Agreement”) confirms the agreement of Allurion Technologies, Inc., a Delaware corporation (the “Company”), and the holders of the Common Stock listed on Schedule I attached hereto (the “Stockholders”), pursuan... |
| 23 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On July 17, 2026, Shantanu K. Gaur, M.D. notified Allurion Technologies, Inc. (the “Company”) of his resignation as Chief Executive Officer of the Company and as a member of the Company's board of directors (the “Board”), in each case ef... |
| 07 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On June 30, 2026, Douglas Hudson, a Class II member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of his resignation from the Board and position on the Nominating and Corpora... |
| 30 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On June 24, 2026, R. Jason Richey, a Class II member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of his resignation from the Board and his role as the chairperson of the Au... |
| 17 Jun 2026 |
8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
ALLURION TECHNOLOGIES, INC., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows: |
| 27 May 2026 |
8-K: Changes in Registrant's Certifying Accountant
We have read Item 4.01 of Allurion Technologies, Inc.'s Form 8-K dated May 27, 2026, and have the following comments: |
| 12 Mar 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events
Files appeal to NYSE on decision to initiate delisting proceedings |
| 02 Mar 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events
Allurion Intends to Appeal NYSE Notice of Delisting While Executing Plan to Regain Compliance and Expects to Remain Trading |
| 25 Feb 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UN... |
| 23 Feb 2026 |
8-K: Regulation FD Disclosure
Approval provides Allurion with access to approximately 80 million Americans with obesity |
| 12 Jan 2026 |
8-K: Results of Operations and Financial Condition
Strong quarter-over-quarter revenue growth with continued, substantial improvement in operating expenses and operating loss |
| 19 Dec 2025 |
8-K: Submission of Matters to a Vote of Security Holders
On December 18, 2025, Allurion Technologies, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) to consider and vote on the seven proposals set forth below, each of which is described in detail in th... |
| 12 Nov 2025 |
8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +2 more
This Securities Purchase Agreement (this “Agreement”) is dated as of November 11, 2025, between Allurion Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, inclu... |
| 03 Oct 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
On September 30, 2025, Milena Alberti-Perez, a Class III member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of her resignation from the Board and her role as the chairperso... |
| 14 Aug 2025 |
8-K: Non-Reliance on Previously Issued Financial Statements
On August 14, 2025, the Audit Committee of the Board of Directors (the “Audit Committee”) of Allurion Technologies, Inc. (the “Company”) concluded that certain of the Company’s previously issued financial statements, as described below, ... |
| 13 Aug 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
NATICK, Mass. – August 13, 2025 – Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced its financial results for the second quarter and provided a business update. |
| 07 Aug 2025 |
8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities +1 more
Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry |
| 14 May 2025 |
8-K: Results of Operations and Financial Condition
NATICK, Mass.—May 14, 2025 — (BUSINESS WIRE) — Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a pioneer in metabolically healthy weight loss, today announced its financial results for the first quarter and provid... |
| 17 Apr 2025 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
This Second Amendment to Note Purchase Agreement (this “Amendment”), dated as of April 15, 2025, is among Allurion Technologies, Inc., a Delaware corporation (together with its successors and permitted assigns, the “Company”), the purcha... |
Loading...